Qureight

Qureight is a pioneering platform designed to accelerate the development of clinical trials, particularly in lung and heart diseases. By leveraging advanced data curation and AI-powered decision-making, Qureight assists pharmaceutical companies, contract research organizations, and hospitals in bringing effective drugs to market faster. Founded by experts in the field, Qureight combines deep medical knowledge with cutting-edge technology to transform healthcare.

The platform's proprietary technology includes AI-based image algorithms for CT scans, AI-assisted workflows, and centralized image read cloud technology. It provides a connected view of lung and heart diseases by backing up AI models with real-world data from partner healthcare institutions. Additionally, Qureight structures and makes clinical trial data accessible to pharmaceutical clients, simplifying the path to drug approval.

Highlights:

• Accelerates drug development for lung and heart diseases
• Combines AI technology with expert medical knowledge
• Facilitates informed decision-making in clinical trials

Key Features:

• Zero-footprint medical imaging viewing
• Efficient AI-guided workflows
• Synthetic study arms generation
• Access to Key Opinion Leaders (KOLs)
• Quantitative imaging analysis

Benefits:

• Speeds up the drug development process
• Improves patient outcomes
• Enhances data analysis in clinical trials
• Provides detailed assessments through AI-powered technology
• Offers insights from leading experts

Use Cases:

• Diagnosing and treating interstitial lung diseases
• Monitoring and treating pulmonary hypertension
• Supporting lung cancer treatment development